Join our newsletter
Get updated info, tips and news about breastfeeding, e-lactancia project and other initiatives from APILAM
Legitimation: Consent of the interested party
As a user and interested I inform you that the data you provide will be located on the servers of MailChimp (email marketing provider of APILAM) outside the EU in the USA. MailChimp is covered by the EU-US Privacy Shield agreement, whose information is available here, approved by the European Committee for Data Protection. See Mailchimp's privacy policy. (https://mailchimp.com/legal/privacy/).
The fact that you do not enter the personal data that appear on the form as mandatory may have the consequence that we can not meet your request.
You can exercise your rights of access, rectification, limitation and delete the data in apilam.es@gmail.com as well as the right to file a claim with a control authority.
You can consult the additional and detailed information on Data Protection on this website: http://e-lactancia.org, as well as consult our own privacy policy.
Topical dermatological and gynecological antiseptic. Also used in oral rinses and for the treatment of canker sores and as a hemostatic in hemorrhoids.
Since the last update we have not found published data on its excretion in breastmilk.
The small dose and the low plasma absorption of most topical dermatological and gynecological preparations make transfer into breastmilk in significant amounts unlikely.
In the case of policresulen, the manufacturer assures that there is no systemic absorption and that it is compatible with breastfeeding (Takeda 2018, CecMed 2018).
When used orally, it must be taken in a highly diluted form followed by rinsing within a few minutes to avoid local irritation and burns (Wardhany 2016).
There is very little literature on this product and/or it is not up to date.